View in EDS PDF Full Text

Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).

Saved in:
Bibliographic Details
Title: Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
Authors: Rivera JC; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Espinoza-Derout J; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States., Hasan KM; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States., Molina-Mancio J; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Martínez J; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Lao CJ; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Lee ML; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; Biostatistics Department, UCLA Fielding School of Public Health, Los Angeles, CA, United States., Lee DL; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Wilson J; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States., Sinha-Hikim AP; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States., Friedman TC; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 May 02; Vol. 15, pp. 1282231. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38756999
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rivera+JC%22">Rivera JC</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Espinoza-Derout+J%22">Espinoza-Derout J</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hasan+KM%22">Hasan KM</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Molina-Mancio+J%22">Molina-Mancio J</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Martínez+J%22">Martínez J</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lao+CJ%22">Lao CJ</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lee+ML%22">Lee ML</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; Biostatistics Department, UCLA Fielding School of Public Health, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Lee+DL%22">Lee DL</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Wilson+J%22">Wilson J</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Sinha-Hikim+AP%22">Sinha-Hikim AP</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.<br /><searchLink fieldCode="AU" term="%22Friedman+TC%22">Friedman TC</searchLink>; Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA, United States.; David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2024 May 02; Vol. 15, pp. 1282231. <i>Date of Electronic Publication: </i>2024 May 02 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38756999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2024.1282231
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1282231
    Titles:
      – TitleFull: Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rivera JC
      – PersonEntity:
          Name:
            NameFull: Espinoza-Derout J
      – PersonEntity:
          Name:
            NameFull: Hasan KM
      – PersonEntity:
          Name:
            NameFull: Molina-Mancio J
      – PersonEntity:
          Name:
            NameFull: Martínez J
      – PersonEntity:
          Name:
            NameFull: Lao CJ
      – PersonEntity:
          Name:
            NameFull: Lee ML
      – PersonEntity:
          Name:
            NameFull: Lee DL
      – PersonEntity:
          Name:
            NameFull: Wilson J
      – PersonEntity:
          Name:
            NameFull: Sinha-Hikim AP
      – PersonEntity:
          Name:
            NameFull: Friedman TC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2024 May 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1664-2392
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in endocrinology
              Type: main
ResultId 1